2H-indazoles as EP2 receptor antagonists

US9062041B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Nico Bräuer · Falkensee, DE
• Anne Mengel · Berlin, DE
• Ulrike Röhn · Berlin, DE
• Andrea Rotgeri · Berlin, DE
• Bernd Buchmann · Hohen Neuendorf, DE
• Bernhard Lindenthal · Berlin, DE
• Antonius Ter Laak · Berlin, DE

Key dates

• Filing date: Nov 26, 2012
• Grant date: Jun 23, 2015
• Expiry date: Nov 26, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP2-receptor.